British Journal of Pharmacology · 2015 · 33 citations · 46 references
Life SciencesPharmacologyPhysiologyCell SignalingMolecular PharmacologyPathophysiologyCirculatory PhysiologyIon Channel DisruptionIon Channel PharmacologyIon Channel PhysiologyIon Channel RegulationIon Channel SignalingCalcium-activated Potassium ChannelsChannelsCirculatory FailureElectrochemical Driving ForceExtravasation MechanismsPotassium Channel PhysiologyTransient Receptor Potential ChannelsTrp Channel Signaling
Background and Purpose The intermediate conductance calcium/calmodulin‐regulated K + channel K Ca 3.1 produces hyperpolarizing K + currents that counteract depolarizing currents carried by transient receptor potential ( TRP ) channels, and provide the electrochemical driving force for C l − and fluid movements. We investigated whether a deficiency in K Ca 3.1 ( K Ca 3.1 −/− ) protects against fatal pulmonary circulatory collapse in mice after pharmacological activation of the calcium‐permeable TRP subfamily vanilloid type 4 ( TRPV 4) channels. Experimental Approach An opener of TRPV 4 channels, GSK 1016790 A , was infused in wild‐type (wt) and K Ca 3.1 −/− mice; haemodynamic parameters, histology and pulmonary vascular reactivity were measured; and patch clamp was performed on pulmonary arterial endothelial cells ( PAEC ). Key Results In wt mice, GSK 1016790 A decreased right ventricular and systemic pressure leading to a fatal circulatory collapse that was accompanied by increased protein permeability, lung haemorrhage and fluid extravasation. In contrast, K Ca 3.1 −/− mice exhibited a significantly smaller drop in pressure to GSK 1016790 A infusion, no haemorrhage and fluid water extravasation, and the mice survived. Moreover, the GSK 1016790 A‐induced relaxation of pulmonary arteries of K Ca 3.1 −/− mice was significantly less than that of wt mice. GSK 1016790 A induced TRPV 4 currents in PAEC from wt and K Ca 3.1 −/− mice, which co‐activated K Ca 3.1 and disrupted membrane resistance in wt PAEC , but not in K Ca 3.1 −/− PAEC . Conclusions and Implications Our findings show that a genetic deficiency of K Ca 3.1 channels prevented fatal pulmonary circulatory collapse and reduced lung damage caused by pharmacological activation of calcium‐permeable TRPV4 channels. Therefore, inhibition of K Ca 3.1 channels may have therapeutic potential in conditions characterized by abnormal high endothelial calcium signalling, barrier disruption, lung oedema and pulmonary circulatory collapse.
46
Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels
Hiroyuki Watanabe, Joris Vriens, Jean Prenen et al. · Nature · 2003 · 1K citations